title: The plasmamembrane calmodulin-dependent calcium pump: a major regulator of nitric oxide synthase I.
abstract: The plasma membrane calcium/calmodulin-dependent calcium ATPase (PMCA) (Shull, G.E., and J. Greeb. 1988. J. Biol. Chem. 263:8646-8657; Verma, A.K., A.G. Filoteo, D.R. Stanford, E.D. Wieben, J.T. Penniston, E.E. Strehler, R. Fischer, R. Heim, G. Vogel, S. Mathews, et al. 1988. J. Biol. Chem. 263:14152-14159; Carafoli, E. 1997. Basic Res. Cardiol. 92:59-61) has been proposed to be a regulator of calcium homeostasis and signal transduction networks of the cell. However, little is known about its precise mechanisms of action. Knock-out of (mainly neuronal) isoform 2 of the enzyme resulted in hearing loss and balance deficits due to severe inner ear defects, affecting formation and maintenance of otoconia (Kozel, P.J., R.A. Friedman, L.C. Erway, E.N. Yamoah, L.H. Liu, T. Riddle, J.J. Duffy, T. Doetschman, M.L. Miller, E.L. Cardell, and G.E. Shull. 1998. J. Biol. Chem. 273:18693-18696). Here we demonstrate that PMCA 4b is a negative regulator of nitric oxide synthase I (NOS-I, nNOS) in HEK293 embryonic kidney and neuro-2a neuroblastoma cell models. Binding of PMCA 4b to NOS-I was mediated by interaction of the COOH-terminal amino acids of PMCA 4b and the PDZ domain of NOS-I (PDZ: PSD 95/Dlg/ZO-1 protein domain). Increasing expression of wild-type PMCA 4b (but not PMCA mutants unable to bind PDZ domains or devoid of Ca2+-transporting activity) dramatically downregulated NO synthesis from wild-type NOS-I. A NOS-I mutant lacking the PDZ domain was not regulated by PMCA, demonstrating the specific nature of the PMCA-NOS-I interaction. Elucidation of PMCA as an interaction partner and major regulator of NOS-I provides evidence for a new dimension of integration between calcium and NO signaling pathways.
authors.affiliation: Department of Medicine, University of Wuerzburg, D-97080 Wuerzburg, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Schuh
authors.forename: S
authors.initials: S
authors.lastname: Uldrijan
authors.forename: M
authors.initials: M
authors.lastname: Telkamp
authors.forename: N
authors.initials: N
authors.lastname: Rothlein
authors.forename: L
authors.initials: L
authors.lastname: Neyses
mesh_terms: D000252:Calcium-Transporting ATPases / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D002147:Calmodulin / Q000502:physiology; D027682:Cation Transport Proteins; D002460:Cell Line; D006801:Humans; D008954:Models, Biological; D009154:Mutation; D009569:Nitric Oxide / Q000096:biosynthesis; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism*; D052248:Nitric Oxide Synthase Type I; D053499:Plasma Membrane Calcium-Transporting ATPases; D017434:Protein Structure, Tertiary; D014162:Transfection; D014407:Tumor Cells, Cultured
chemical_list: D002147:Calmodulin; D027682:Cation Transport Proteins; D009569:Nitric Oxide; C496320:NOS1 protein, human; D019001:Nitric Oxide Synthase; D052248:Nitric Oxide Synthase Type I; D053499:Plasma Membrane Calcium-Transporting ATPases; D000252:Calcium-Transporting ATPases